| sterol metabolic process | GO:0016125 | 58 | 1.000 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.998 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.997 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.996 | |
| phospholipid transfer to membrane | GO:0006649 | 2 | 0.995 | |
| positive regulation of sterol transport | GO:0032373 | 9 | 0.993 | |
| reverse cholesterol transport | GO:0043691 | 6 | 0.987 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.987 | |
| positive regulation of cholesterol transport | GO:0032376 | 9 | 0.985 | |
| positive regulation of reverse cholesterol transport | GO:1903064 | 1 | 0.978 | |
| regulation of beta amyloid clearance | GO:1900221 | 1 | 0.963 | |
| regulation of cholesterol transport | GO:0032374 | 17 | 0.959 | |
| regulation of insulin receptor signaling pathway | GO:0046626 | 21 | 0.954 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.952 | |
| beta amyloid clearance | GO:0097242 | 2 | 0.947 | |
| lipid homeostasis | GO:0055088 | 63 | 0.945 | |
| respiratory system development | GO:0060541 | 190 | 0.936 | |
| sterol transport | GO:0015918 | 38 | 0.934 | |
| cholesterol transport | GO:0030301 | 38 | 0.927 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.926 | |
| positive regulation of beta amyloid clearance | GO:1900223 | 1 | 0.926 | |
| lung development | GO:0030324 | 164 | 0.913 | |
| steroid metabolic process | GO:0008202 | 119 | 0.906 | |
| regulation of phospholipid efflux | GO:1902994 | 2 | 0.904 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.901 | |
| regulation of sterol transport | GO:0032371 | 17 | 0.899 | |
| fat cell differentiation | GO:0045444 | 160 | 0.898 | |
| cellular response to peptide | GO:1901653 | 92 | 0.888 | |
| positive regulation of cholesterol efflux | GO:0010875 | 9 | 0.886 | |
| cholesterol efflux | GO:0033344 | 24 | 0.879 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.877 | |
| lipoprotein metabolic process | GO:0042157 | 43 | 0.869 | |
| lipoprotein biosynthetic process | GO:0042158 | 33 | 0.854 | |
| glucose homeostasis | GO:0042593 | 128 | 0.851 | |
| positive regulation of lipid transport | GO:0032370 | 22 | 0.843 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.843 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.825 | |
| respiratory tube development | GO:0030323 | 167 | 0.824 | |
| lipid transport | GO:0006869 | 98 | 0.815 | |
| negative regulation of cellular amide metabolic process | GO:0034249 | 4 | 0.815 | |
| regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:2000161 | 1 | 0.810 | |
| receptor mediated endocytosis of low density lipoprotein particle involved in cholesterol transport | GO:0090118 | 1 | 0.809 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.808 | |
| negative regulation of sterol transport | GO:0032372 | 4 | 0.791 | |
| stem cell maintenance | GO:0019827 | 130 | 0.791 | |
| peptide secretion | GO:0002790 | 114 | 0.790 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.786 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.776 | Mouse |
| insulin receptor signaling pathway | GO:0008286 | 49 | 0.764 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.762 | |
| negative regulation of planar cell polarity pathway involved in heart morphogenesis | GO:2000160 | 1 | 0.746 | |
| stem cell development | GO:0048864 | 219 | 0.744 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.728 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.727 | |
| regulation of fatty acid metabolic process | GO:0019217 | 28 | 0.725 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.720 | |
| lipid localization | GO:0010876 | 126 | 0.711 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.708 | |
| glucose metabolic process | GO:0006006 | 92 | 0.701 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.700 | |
| negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:2000162 | 1 | 0.695 | |
| amine metabolic process | GO:0009308 | 45 | 0.689 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.688 | |
| positive regulation of phagocytosis | GO:0050766 | 26 | 0.684 | |
| positive regulation of phagocytosis engulfment | GO:0060100 | 3 | 0.682 | |
| negative regulation of planar cell polarity pathway involved in pericardium morphogenesis | GO:2000166 | 1 | 0.674 | |
| regulation of presynaptic membrane organization | GO:1901629 | 3 | 0.672 | |
| skin development | GO:0043588 | 220 | 0.670 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.660 | |
| epidermis development | GO:0008544 | 187 | 0.659 | |
| negative regulation of beta amyloid formation | GO:1902430 | 4 | 0.658 | |
| plasma lipoprotein particle clearance | GO:0034381 | 13 | 0.656 | |
| regulation of planar cell polarity pathway involved in outflow tract morphogenesis | GO:2000163 | 1 | 0.655 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.652 | Mouse |
| gliogenesis | GO:0042063 | 141 | 0.651 | |
| intracellular cholesterol transport | GO:0032367 | 3 | 0.649 | |
| regulation of engulfment of apoptotic cell | GO:1901074 | 2 | 0.648 | |
| response to peptide hormone | GO:0043434 | 127 | 0.642 | |
| oxidation reduction process | GO:0055114 | 342 | 0.638 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.637 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.636 | Mouse |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.633 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.631 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.629 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.629 | |
| regulation of lipid transport | GO:0032368 | 36 | 0.625 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.618 | |
| regulation of planar cell polarity pathway involved in ventricular septum morphogenesis | GO:2000148 | 1 | 0.616 | |
| lipid catabolic process | GO:0016042 | 69 | 0.605 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.603 | Mouse |
| regulation of homeostatic process | GO:0032844 | 182 | 0.598 | |
| hexose metabolic process | GO:0019318 | 98 | 0.585 | |
| regulation of phospholipid transport | GO:2001138 | 4 | 0.585 | |
| regulation of reverse cholesterol transport | GO:1903062 | 1 | 0.571 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.570 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.569 | |
| mitochondrion organization | GO:0007005 | 134 | 0.557 | |
| pyruvate metabolic process | GO:0006090 | 28 | 0.555 | |
| regulation of phagocytosis engulfment | GO:0060099 | 5 | 0.553 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.552 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.550 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.548 | |
| acylglycerol catabolic process | GO:0046464 | 11 | 0.545 | |
| mapk cascade | GO:0000165 | 281 | 0.544 | |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.542 | |
| cell maturation | GO:0048469 | 127 | 0.540 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.534 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.525 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.523 | |
| phospholipid efflux | GO:0033700 | 3 | 0.521 | |
| positive regulation of fat cell differentiation | GO:0045600 | 32 | 0.520 | |
| regulation of amyloid precursor protein catabolic process | GO:1902991 | 8 | 0.518 | |
| positive regulation of triglyceride metabolic process | GO:0090208 | 9 | 0.516 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.516 | |
| single organism nuclear import | GO:1902593 | 95 | 0.514 | |
| lung alveolus development | GO:0048286 | 45 | 0.511 | |
| cholesterol esterification | GO:0034435 | 3 | 0.509 | |
| regulation of phospholipase a2 activity | GO:0032429 | 3 | 0.501 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.495 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.491 | |
| positive regulation of phospholipid transport | GO:2001140 | 4 | 0.490 | |
| formation of radial glial scaffolds | GO:0021943 | 4 | 0.486 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.483 | |
| stem cell differentiation | GO:0048863 | 268 | 0.482 | |
| mammary gland morphogenesis | GO:0060443 | 54 | 0.478 | |
| transmembrane transport | GO:0055085 | 412 | 0.475 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.472 | |
| acylglycerol biosynthetic process | GO:0046463 | 18 | 0.466 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.465 | |
| negative regulation of platelet derived growth factor receptor beta signaling pathway | GO:2000587 | 2 | 0.460 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.458 | |
| glycogen metabolic process | GO:0005977 | 32 | 0.454 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.451 | Mouse |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.448 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.444 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.441 | |
| regulation of lipid catabolic process | GO:0050994 | 15 | 0.434 | |
| protein localization to organelle | GO:0033365 | 185 | 0.434 | |
| regulation of amyloid precursor protein biosynthetic process | GO:0042984 | 3 | 0.432 | |
| positive regulation of apoptotic cell clearance | GO:2000427 | 3 | 0.431 | |
| myotube differentiation | GO:0014902 | 105 | 0.426 | |
| ossification | GO:0001503 | 216 | 0.425 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.422 | |
| negative regulation of fat cell differentiation | GO:0045599 | 36 | 0.420 | |
| carbohydrate catabolic process | GO:0016052 | 32 | 0.417 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.415 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.415 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.411 | Mouse |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.407 | |
| inflammatory response | GO:0006954 | 244 | 0.401 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.398 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.397 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.397 | |
| multicellular organism growth | GO:0035264 | 161 | 0.397 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.395 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.394 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.394 | |
| negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis | GO:2000164 | 1 | 0.393 | |
| negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis | GO:2000149 | 1 | 0.389 | |
| amyloid precursor protein biosynthetic process | GO:0042983 | 3 | 0.386 | |
| positive regulation of ion transport | GO:0043270 | 65 | 0.385 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.384 | |
| circadian rhythm | GO:0007623 | 114 | 0.382 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.378 | |
| planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:0061350 | 2 | 0.376 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.373 | |
| glycolytic process | GO:0006096 | 20 | 0.373 | |
| regulation of smooth muscle cell migration | GO:0014910 | 6 | 0.373 | |
| urea cycle | GO:0000050 | 2 | 0.372 | |
| keratinocyte differentiation | GO:0030216 | 48 | 0.368 | |
| urogenital system development | GO:0001655 | 261 | 0.368 | |
| negative regulation of amyloid precursor protein biosynthetic process | GO:0042985 | 2 | 0.368 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.365 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.365 | |
| female gonad development | GO:0008585 | 71 | 0.363 | |
| organophosphate ester transport | GO:0015748 | 28 | 0.363 | |
| lung morphogenesis | GO:0060425 | 50 | 0.361 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.359 | |
| cytokine production | GO:0001816 | 319 | 0.357 | Mouse |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.355 | |
| regulation of ossification | GO:0030278 | 112 | 0.348 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.346 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.346 | |
| positive regulation of adaptive immune response | GO:0002821 | 61 | 0.346 | |
| positive regulation of protein ubiquitination involved in ubiquitin dependent protein catabolic process | GO:2000060 | 8 | 0.340 | |
| external genitalia morphogenesis | GO:0035261 | 1 | 0.340 | |
| oocyte maturation | GO:0001556 | 18 | 0.336 | |
| cognition | GO:0050890 | 149 | 0.334 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.330 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.328 | |
| sterol homeostasis | GO:0055092 | 45 | 0.327 | |
| regulation of protein localization | GO:0032880 | 231 | 0.327 | |
| positive regulation of gluconeogenesis | GO:0045722 | 11 | 0.325 | |
| regulation of cholesterol efflux | GO:0010874 | 13 | 0.322 | |
| phospholipid transport | GO:0015914 | 21 | 0.318 | |
| monosaccharide transport | GO:0015749 | 58 | 0.313 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.310 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.310 | |
| membrane invagination | GO:0010324 | 17 | 0.307 | |
| response to insulin | GO:0032868 | 100 | 0.306 | |
| positive regulation of nitric oxide synthase activity | GO:0051000 | 2 | 0.306 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.301 | |
| kidney development | GO:0001822 | 213 | 0.300 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.300 | |
| telencephalon development | GO:0021537 | 186 | 0.299 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.298 | |
| regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:2000150 | 1 | 0.298 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.297 | |
| defense response to other organism | GO:0098542 | 197 | 0.297 | Mouse |
| gland development | GO:0048732 | 330 | 0.293 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.292 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.291 | |
| triglyceride biosynthetic process | GO:0019432 | 17 | 0.291 | |
| cellular response to lipid | GO:0071396 | 145 | 0.291 | |
| negative regulation of cholesterol transport | GO:0032375 | 4 | 0.291 | |
| sterol esterification | GO:0034434 | 3 | 0.289 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.287 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.286 | |
| protein lipidation | GO:0006497 | 28 | 0.286 | |
| cellular glucan metabolic process | GO:0006073 | 32 | 0.286 | |
| amide transport | GO:0042886 | 138 | 0.285 | |
| response to peptide | GO:1901652 | 136 | 0.284 | |
| glucan metabolic process | GO:0044042 | 32 | 0.283 | |
| digestive tract development | GO:0048565 | 190 | 0.282 | |
| cell proliferation involved in outflow tract morphogenesis | GO:0061325 | 4 | 0.280 | |
| response to monosaccharide | GO:0034284 | 67 | 0.280 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.279 | |
| regulation of beta amyloid formation | GO:1902003 | 8 | 0.279 | |
| insulin secretion | GO:0030073 | 89 | 0.276 | |
| glycerolipid catabolic process | GO:0046503 | 16 | 0.275 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.274 | |
| brown fat cell differentiation | GO:0050873 | 36 | 0.274 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.273 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.273 | |
| negative regulation of cellular response to insulin stimulus | GO:1900077 | 16 | 0.272 | |
| neutral lipid biosynthetic process | GO:0046460 | 18 | 0.271 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.271 | |
| vitamin metabolic process | GO:0006766 | 23 | 0.271 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.270 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.269 | |
| low density lipoprotein particle clearance | GO:0034383 | 8 | 0.268 | |
| negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:2000151 | 1 | 0.267 | |
| positive regulation of endocytosis | GO:0045807 | 42 | 0.265 | |
| regulation of cholesterol biosynthetic process | GO:0045540 | 8 | 0.265 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.263 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.263 | |
| chromatin organization | GO:0006325 | 206 | 0.261 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.260 | |
| innate immune response | GO:0045087 | 157 | 0.259 | |
| mammary gland involution | GO:0060056 | 9 | 0.259 | |
| negative regulation of cell size | GO:0045792 | 3 | 0.259 | |
| canonical wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development | GO:0061310 | 1 | 0.256 | |
| regulation of defense response | GO:0031347 | 233 | 0.253 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.253 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.249 | |
| skeletal system development | GO:0001501 | 356 | 0.247 | |
| positive regulation of presynaptic membrane organization | GO:1901631 | 1 | 0.247 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.246 | |
| regulation of cellular ketone metabolic process by regulation of transcription from rna polymerase ii promoter | GO:0072364 | 7 | 0.245 | |
| regulation of cell migration | GO:0030334 | 219 | 0.244 | |
| endocytosis | GO:0006897 | 168 | 0.243 | Mouse |
| positive regulation of phospholipid efflux | GO:1902995 | 2 | 0.243 | |
| organic anion transport | GO:0015711 | 137 | 0.242 | |
| positive regulation of glycolytic process | GO:0045821 | 4 | 0.238 | |
| positive regulation of protein localization to cell surface | GO:2000010 | 2 | 0.238 | |
| response to increased oxygen levels | GO:0036296 | 2 | 0.237 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.236 | |
| dna metabolic process | GO:0006259 | 303 | 0.236 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.235 | |
| regulation of planar cell polarity pathway involved in neural tube closure | GO:2000167 | 1 | 0.235 | |
| regulation of ammonia assimilation cycle | GO:2001248 | 1 | 0.235 | |
| planar cell polarity pathway involved in outflow tract morphogenesis | GO:0061347 | 2 | 0.234 | |
| apoptotic process involved in morphogenesis | GO:0060561 | 25 | 0.234 | |
| chromatin modification | GO:0016568 | 187 | 0.232 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.231 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.231 | |
| regulation of receptor activity | GO:0010469 | 41 | 0.231 | |
| regulation of binding | GO:0051098 | 111 | 0.229 | |
| bone development | GO:0060348 | 120 | 0.229 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.227 | |
| regulation of phagocytosis | GO:0050764 | 33 | 0.227 | |
| somatic stem cell maintenance | GO:0035019 | 47 | 0.226 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.225 | |
| regulation of platelet derived growth factor receptor beta signaling pathway | GO:2000586 | 2 | 0.225 | |
| cellular response to retinoic acid | GO:0071300 | 25 | 0.223 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.223 | |
| memory | GO:0007613 | 58 | 0.223 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.222 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.222 | |
| intracellular sterol transport | GO:0032366 | 3 | 0.222 | |
| positive regulation of ossification | GO:0045778 | 47 | 0.222 | |
| response to endoplasmic reticulum stress | GO:0034976 | 53 | 0.220 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.218 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 58 | 0.218 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.216 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.216 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.215 | |
| water homeostasis | GO:0030104 | 27 | 0.215 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.215 | |
| sensory perception of light stimulus | GO:0050953 | 54 | 0.213 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.212 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.212 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.211 | |
| glial cell differentiation | GO:0010001 | 131 | 0.211 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.211 | Mouse |
| negative regulation of cardiac chamber morphogenesis | GO:1901220 | 2 | 0.210 | |
| regulation of triglyceride biosynthetic process | GO:0010866 | 10 | 0.209 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.209 | |
| positive regulation of fatty acid oxidation | GO:0046321 | 4 | 0.208 | |
| beta amyloid formation | GO:0034205 | 9 | 0.208 | |
| cholesterol storage | GO:0010878 | 4 | 0.208 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.208 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.208 | |
| negative regulation of homeostatic process | GO:0032845 | 71 | 0.207 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.206 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.205 | |
| angiogenesis | GO:0001525 | 201 | 0.205 | |
| regulation of planar cell polarity pathway involved in heart morphogenesis | GO:2000159 | 1 | 0.204 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.203 | |
| response to lithium ion | GO:0010226 | 10 | 0.201 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.199 | |
| peptide metabolic process | GO:0006518 | 46 | 0.198 | |
| establishment of skin barrier | GO:0061436 | 14 | 0.198 | |
| chemical homeostasis within a tissue | GO:0048875 | 9 | 0.197 | |
| membrane organization | GO:0061024 | 245 | 0.197 | |
| positive regulation of engulfment of apoptotic cell | GO:1901076 | 1 | 0.197 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.197 | |
| anion transport | GO:0006820 | 177 | 0.196 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.196 | |
| cellular response to increased oxygen levels | GO:0036295 | 1 | 0.196 | |
| negative regulation of glycoprotein metabolic process | GO:1903019 | 3 | 0.195 | |
| regulation of lipid biosynthetic process | GO:0046890 | 54 | 0.194 | |
| polysaccharide metabolic process | GO:0005976 | 39 | 0.193 | |
| nitrogen cycle metabolic process | GO:0071941 | 3 | 0.192 | |
| regulation of secretion | GO:0051046 | 274 | 0.191 | |
| regulation of gluconeogenesis | GO:0006111 | 30 | 0.191 | |
| lipid storage | GO:0019915 | 36 | 0.191 | |
| positive regulation of intracellular transport | GO:0032388 | 70 | 0.190 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.190 | |
| germ cell development | GO:0007281 | 185 | 0.189 | |
| positive regulation of apoptotic process involved in mammary gland involution | GO:0060058 | 4 | 0.188 | |
| visual perception | GO:0007601 | 52 | 0.188 | |
| positive regulation of growth | GO:0045927 | 104 | 0.188 | |
| cardiac right atrium morphogenesis | GO:0003213 | 3 | 0.188 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.188 | |
| epithelial cell development | GO:0002064 | 159 | 0.187 | |
| energy reserve metabolic process | GO:0006112 | 39 | 0.187 | |
| amyloid precursor protein catabolic process | GO:0042987 | 10 | 0.187 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.186 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.186 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.185 | |
| response to acid chemical | GO:0001101 | 111 | 0.185 | Mouse |
| positive regulation of insulin receptor signaling pathway | GO:0046628 | 4 | 0.185 | |
| apoptotic process involved in patterning of blood vessels | GO:1902262 | 6 | 0.184 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.184 | |
| positive regulation of glucose transport | GO:0010828 | 16 | 0.184 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.183 | |
| response to nutrient levels | GO:0031667 | 109 | 0.183 | |
| intestinal cholesterol absorption | GO:0030299 | 5 | 0.182 | |
| response to retinoic acid | GO:0032526 | 56 | 0.181 | |
| cellular response to hexose stimulus | GO:0071331 | 47 | 0.181 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.180 | |
| response to low density lipoprotein particle | GO:0055098 | 2 | 0.180 | |
| negative regulation of map kinase activity | GO:0043407 | 34 | 0.179 | |
| regulation of planar cell polarity pathway involved in pericardium morphogenesis | GO:2000165 | 1 | 0.179 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.178 | |
| positive regulation of lipid biosynthetic process | GO:0046889 | 18 | 0.177 | |
| cytokine biosynthetic process | GO:0042089 | 68 | 0.176 | Mouse |
| canonical wnt signaling pathway involved in regulation of cell proliferation | GO:0044340 | 3 | 0.176 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 43 | 0.175 | |
| regulation of cell activation | GO:0050865 | 289 | 0.175 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.174 | |
| lung epithelial cell differentiation | GO:0060487 | 29 | 0.173 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.173 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.171 | |
| phospholipid translocation | GO:0045332 | 9 | 0.171 | |
| intracellular protein transport | GO:0006886 | 204 | 0.170 | |
| cerebellar granule cell precursor proliferation | GO:0021930 | 10 | 0.170 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.170 | |
| photoreceptor cell maintenance | GO:0045494 | 19 | 0.170 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.170 | |
| peptide transport | GO:0015833 | 133 | 0.169 | |
| cellular response to carbohydrate stimulus | GO:0071322 | 50 | 0.169 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.168 | |
| retina homeostasis | GO:0001895 | 23 | 0.168 | |
| developmental programmed cell death | GO:0010623 | 41 | 0.167 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.166 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.166 | |
| cellular polysaccharide metabolic process | GO:0044264 | 38 | 0.165 | |
| release of cytochrome c from mitochondria | GO:0001836 | 23 | 0.165 | |
| pallium development | GO:0021543 | 120 | 0.164 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.164 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.163 | |
| t cell activation | GO:0042110 | 289 | 0.162 | |
| negative regulation of erythrocyte differentiation | GO:0045647 | 5 | 0.161 | |
| cellular lipid catabolic process | GO:0044242 | 52 | 0.161 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.161 | |
| forebrain development | GO:0030900 | 302 | 0.161 | |
| cation transport | GO:0006812 | 399 | 0.158 | |
| planar cell polarity pathway involved in pericardium morphogenesis | GO:0061354 | 2 | 0.158 | |
| regulation of carbohydrate biosynthetic process | GO:0043255 | 40 | 0.158 | |
| cellular response to monosaccharide stimulus | GO:0071326 | 47 | 0.158 | |
| regulation of anion transport | GO:0044070 | 27 | 0.158 | |
| positive regulation of macroautophagy | GO:0016239 | 3 | 0.158 | |
| neutral lipid catabolic process | GO:0046461 | 11 | 0.157 | |
| lipid modification | GO:0030258 | 65 | 0.157 | |
| rhythmic process | GO:0048511 | 174 | 0.154 | |
| acylglycerol homeostasis | GO:0055090 | 16 | 0.154 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.154 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.154 | |
| negative regulation of growth | GO:0045926 | 99 | 0.154 | |
| apoptotic process involved in development | GO:1902742 | 28 | 0.154 | |
| negative regulation of mapk cascade | GO:0043409 | 65 | 0.153 | |
| neuron death | GO:0070997 | 154 | 0.152 | Mouse |
| cholesterol import | GO:0070508 | 2 | 0.151 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.150 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.149 | |
| regulation of plasma lipoprotein particle levels | GO:0097006 | 23 | 0.148 | |
| positive regulation of protein catabolic process | GO:0045732 | 60 | 0.147 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.147 | |
| negative regulation of release of cytochrome c from mitochondria | GO:0090201 | 6 | 0.147 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.146 | |
| methylation | GO:0032259 | 134 | 0.146 | |
| response to granulocyte macrophage colony stimulating factor | GO:0097012 | 3 | 0.145 | |
| mammary gland duct morphogenesis | GO:0060603 | 38 | 0.145 | |
| adaptive immune response | GO:0002250 | 155 | 0.145 | |
| tissue remodeling | GO:0048771 | 102 | 0.144 | |
| cell proliferation in external granule layer | GO:0021924 | 10 | 0.144 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.143 | |
| phagocytosis | GO:0006909 | 66 | 0.143 | Mouse |
| regulation of glucose transport | GO:0010827 | 32 | 0.142 | |
| hair cycle | GO:0042633 | 90 | 0.141 | |
| planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:0061349 | 2 | 0.141 | |
| response to amino acid | GO:0043200 | 37 | 0.141 | Mouse |
| cellular amine metabolic process | GO:0044106 | 44 | 0.140 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.139 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.139 | |
| cellular carbohydrate catabolic process | GO:0044275 | 15 | 0.139 | |
| regulation of erythrocyte differentiation | GO:0045646 | 23 | 0.138 | |
| positive regulation of glial cell proliferation | GO:0060252 | 4 | 0.138 | |
| regulation of cytokine biosynthetic process | GO:0042035 | 59 | 0.137 | Mouse |
| negative regulation of defense response | GO:0031348 | 77 | 0.137 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.137 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.136 | |
| forelimb morphogenesis | GO:0035136 | 40 | 0.136 | |
| outflow tract morphogenesis | GO:0003151 | 53 | 0.136 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.135 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.135 | |
| triglyceride homeostasis | GO:0070328 | 15 | 0.134 | |
| positive regulation of activated t cell proliferation | GO:0042104 | 8 | 0.134 | |
| negative regulation of non canonical wnt signaling pathway | GO:2000051 | 5 | 0.133 | |
| limb development | GO:0060173 | 166 | 0.133 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.133 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.131 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.131 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.130 | Mouse |
| keratinization | GO:0031424 | 9 | 0.130 | |
| glucose transport | GO:0015758 | 56 | 0.130 | |
| response to radiation | GO:0009314 | 165 | 0.129 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.128 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.128 | |
| regulation of carbohydrate catabolic process | GO:0043470 | 12 | 0.128 | |
| regulation of mitochondrion organization | GO:0010821 | 27 | 0.128 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.127 | Mouse |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.126 | |
| cellular glucose homeostasis | GO:0001678 | 52 | 0.126 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.125 | |
| wound healing | GO:0042060 | 157 | 0.125 | |
| lung cell differentiation | GO:0060479 | 30 | 0.125 | |
| regulation of natural killer cell differentiation | GO:0032823 | 11 | 0.125 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.124 | |
| positive regulation of steroid biosynthetic process | GO:0010893 | 4 | 0.124 | |
| cellular response to hyperoxia | GO:0071455 | 1 | 0.124 | |
| negative regulation of wnt signaling pathway involved in heart development | GO:0003308 | 4 | 0.123 | |
| tissue homeostasis | GO:0001894 | 115 | 0.123 | |
| protein catabolic process | GO:0030163 | 221 | 0.122 | |
| glucose import | GO:0046323 | 32 | 0.122 | |
| amyloid precursor protein metabolic process | GO:0042982 | 13 | 0.122 | |
| organ regeneration | GO:0031100 | 2 | 0.121 | |
| neural tube development | GO:0021915 | 160 | 0.121 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.121 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.120 | |
| negative regulation of myeloid cell differentiation | GO:0045638 | 38 | 0.119 | |
| positive regulation of autophagy | GO:0010508 | 9 | 0.119 | |
| urea metabolic process | GO:0019627 | 3 | 0.119 | |
| regulation of ion transport | GO:0043269 | 215 | 0.119 | |
| regulation of lipid storage | GO:0010883 | 20 | 0.118 | |
| astrocyte differentiation | GO:0048708 | 43 | 0.117 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.117 | Mouse |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.117 | |
